NL-OMON54176招募中不适用
TAAI Erasmus Research Initiative to Fight CF: Monitoring Inflammation in CF Lung disease into a new Era - TERRIFIC-MILE
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 103
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 2 至 99（—）
入选标准
- •In order to be eligible to participate in this study, a subject must meet all
- •of the following criteria:
- •Diagnosed with cystic fibrosis (CF), either by abnormal sweat test and/or
- •confirmed with 2 CF causing mutations found by genetic analysis, either from
- •heel-prick screening or diagnosed later in life. Furthermore, they have to be
- •older than 6 years (i.e. children and adults). Age appropriate written informed
- •consent is required.
- •In addition, patients need to meet the criteria of one of the following study
- •Group 1: CF patients, whom are eligible to start
- •elexacaftor/tezacaftor/ivacaftor treatment or who are already using it.
- •Group 2: CF patients, whom are not eligible to receive
- •elexacaftor/tezacaftor/ivacaftor treatment. This group will function as
排除标准
- •- Patients who cannot follow instructions
研究者
相似试验
已完成
不适用
TAAI Erasmus Research Initiative to Fight CF: Monitoring Inflammation in CF Lung Disease Into a New EraLung InflammationLung InfectionLung DiseasesInflammation LungsCongenital DisordersExacerbation, SymptomInfections, BacterialCystic FibrosisLung Disease CysticLung Disease Cystic, CongenitalNCT05752019Erasmus Medical Center103
进行中（未招募）
1 期
Clinical trial for the treatment of COVID-19 and COVID-like illness in primary careCOVID-19, COVID-like-illnessMedDRA version: 21.1Level: PTClassification code: 10068724Term: Antiviral treatment Class: 100000004865CTIS2022-501707-27-01niversity Medical Center Utrecht1,001
进行中（未招募）
不适用
Clinical trial for the treatment of COVID-19 and COVID-like illness in primary careReducing illness duration, complications, and possibly transmission of COVID-19 (SARS-CoV-2 infection) and other respiratory pathogensInfections and InfestationsISRCTN55471843niversity Medical Center Utrecht1,700
招募中
不适用
A Research Study to Advance the CF Therapeutics Pipeline for People Without ModulatorsCystic FibrosisNCT06504589Nicole Hamblett400
进行中（未招募）
1 期
A clinical study to evaluate the efficacy of different anti-viral drugs inSARS-CoV-2 infected patients (COVID-19)SARS-COV-2 infectionMedDRA version: 21.1Level: LLTClassification code 10037373Term: Pulmonary disorderSystem Organ Class: 100000004855EUCTR2020-001784-88-FIniversity of Helsinki582